Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: A composite biomarker of neutrophil-lymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers

Fig. 2

Association of NLR with TTD (a-d) and OS (e-h). Kaplan-Meier curves are shown for NLR ≥ 5 and NLR < 5 patients at baseline (time 0, < 30 days prior to treatment) (a, e), 2–8 weeks (b, f), and 8–14 weeks (c, g), or increase in NLR from baseline to 2–8 weeks ≥1 and < 1 (D, H)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us